Vanadium Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2018
About Vanadium Pharmaceuticals
Vanadium Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 June 2017 (Seven years and seven months 18 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Jai, Bhanwar Singh, Vijay Rathi, and One other member serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999PN2017PTC171005
-
Company No.
171005
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jun 2017
-
Date of AGM
31 Dec 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Vanadium Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Rathi
|
Additional Director | 01-Jun-2021 | Current |
|
Anil Jai
|
Director | 15-Jun-2017 | Current |
|
Bhanwar Singh
|
Director | 15-Jun-2017 | Current |
|
Mahendra Kanwar
|
Director | 15-Jun-2017 | Current |
Financial Performance of Vanadium Pharmaceuticals.
Vanadium Pharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vanadium Pharmaceuticals?
In 2018, Vanadium Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vasuchem Lifesciences Private LimitedVijay Rathi is a mutual person
-
Incco International Private LimitedAnil Jai is a mutual person
-
Sudershan Greens Private Limited
Anil Jai is a mutual person
-
Sudershan Mach Impex Private Limited
Anil Jai is a mutual person
-
Jayant Infrahomes Private Limited
Anil Jai is a mutual person
-
Vcareplus Distribution Private Limited
Anil Jai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vanadium Pharmaceuticals?
Unlock and access historical data on people associated with Vanadium Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vanadium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanadium Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.